MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Omnicell Inc

Chiusa

SettoreSettore sanitario

29.75 -1.29

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

29.75

Massimo

29.98

Metriche Chiave

By Trading Economics

Entrata

13M

5.6M

Vendite

21M

291M

P/E

Media del settore

58.92

36.442

Margine di Profitto

1.941

Dipendenti

3,650

EBITDA

42M

30M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+41.3% upside

Dividendi

By Dow Jones

Utili prossimi

30 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

6.7M

1.4B

Apertura precedente

31.04

Chiusura precedente

29.75

Notizie sul Sentiment di mercato

By Acuity

50%

50%

148 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Omnicell Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 ott 2025, 18:13 UTC

I principali Market Mover

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 ott 2025, 17:05 UTC

I principali Market Mover

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

18 ott 2025, 13:30 UTC

Acquisizioni, Fusioni, Takeovers

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18 ott 2025, 13:30 UTC

Acquisizioni, Fusioni, Takeovers

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18 ott 2025, 13:30 UTC

Acquisizioni, Fusioni, Takeovers

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18 ott 2025, 13:30 UTC

Acquisizioni, Fusioni, Takeovers

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18 ott 2025, 08:20 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

17 ott 2025, 23:25 UTC

Acquisizioni, Fusioni, Takeovers

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 ott 2025, 22:15 UTC

Discorsi di Mercato

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 ott 2025, 21:15 UTC

Discorsi di Mercato

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 ott 2025, 21:07 UTC

Discorsi di Mercato

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 ott 2025, 21:07 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

17 ott 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

17 ott 2025, 20:34 UTC

Discorsi di Mercato

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 ott 2025, 20:27 UTC

Discorsi di Mercato

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 ott 2025, 19:46 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 ott 2025, 19:45 UTC

Discorsi di Mercato

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 ott 2025, 18:45 UTC

Discorsi di Mercato

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 ott 2025, 17:51 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

17 ott 2025, 17:51 UTC

Discorsi di Mercato

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 ott 2025, 17:44 UTC

Discorsi di Mercato

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 ott 2025, 17:35 UTC

Discorsi di Mercato

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 ott 2025, 16:20 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

17 ott 2025, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

17 ott 2025, 16:14 UTC

Discorsi di Mercato

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 ott 2025, 16:04 UTC

Discorsi di Mercato

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 ott 2025, 15:58 UTC

Discorsi di Mercato

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 ott 2025, 15:56 UTC

Utili

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 ott 2025, 15:43 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

17 ott 2025, 15:43 UTC

Discorsi di Mercato

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

Confronto tra pari

Modifica del prezzo

Omnicell Inc Previsione

Obiettivo di Prezzo

By TipRanks

41.3% in crescita

Previsioni per 12 mesi

Media 42.25 USD  41.3%

Alto 55 USD

Basso 34 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Omnicell Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

6 ratings

4

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

24.23 / 30.44Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

148 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat